Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Correlation coefficient inference on censored bioassay data.

Liang Li1, William W B Wang, Ivan S F Chan

  • 1Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. lli@bio.ri.ccf.org

Journal of Biopharmaceutical Statistics
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An enhanced exact permutation rank-based inferential seamless phase 2/3 design.

Journal of biopharmaceutical statistics·2026
Same author

A rank-based approach to improve the efficiency of inferential seamless phase 2/3 clinical trials with dose optimization.

Contemporary clinical trials·2023
Same author

A practical response adaptive block randomization (RABR) design with analytic type I error protection.

Statistics in medicine·2021
Same author

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.

The Lancet. Infectious diseases·2019
Same author

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2018
Same author

Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.

Vaccine·2017
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces a new statistical method for analyzing censored immunologic assay data in vaccine trials. The approach accurately estimates correlation coefficients and confidence intervals, simplifying analysis for censored measurements.

Area of Science:

  • Biostatistics
  • Immunology
  • Vaccine Development

Background:

  • Bioassays in vaccine trials can yield censored data, where exact measurements are unavailable.
  • Censored data arises from methods like serial dilution or assays with detection limits.
  • Accurate statistical analysis of censored immunologic responses is crucial for vaccine efficacy assessment.

Purpose of the Study:

  • To develop a method for computing confidence intervals for correlation coefficients of censored bioassay measurements.
  • To extend the Fisher Z transformation to accommodate censored data in immunologic assays.
  • To provide a computationally simpler and effective alternative to existing methods for censored data analysis.

Main Methods:

  • Utilizing maximum likelihood estimation to determine the correlation coefficient.

Related Experiment Videos

  • Employing a second-order Taylor expansion of the Fisher Z transformation for confidence interval construction.
  • Developing a Monte Carlo exact test for model goodness-of-fit assessment.

    • Main Results:

    • The proposed method demonstrates satisfactory coverage probabilities in simulations with finite sample sizes.
    • The method performs comparably to existing approaches but with significantly reduced computational complexity.
    • The technique is adaptable to various types of censored immunologic assay data.

    Conclusions:

    • The novel maximum likelihood-based method effectively handles censored data in vaccine trial bioassays.
    • This approach offers a computationally efficient and robust tool for analyzing immunologic response correlations.
    • The proposed method enhances the statistical rigor of vaccine clinical trial data analysis.